Assessing the validity, responsiveness and reliability of the RECAP measure of eczema control

Alisha Bhanot; TJ Peters; Matthew J Ridd

doi:10.1111/bjd.19709

Assessing the validity, responsiveness and reliability of the RECAP measure of eczema control

Alisha Bhanot, TJ Peters, Matthew J Ridd^*

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Abstract

Research comparing the effectiveness of different eczema treatments is limited by inconsistency in both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for Eczema) recommends a core set of outcomes to be reported in all trials of eczema treatments.1 RECAP (RECap for AtoPic eczema) is a seven‐item patient‐reported instrument recommended for capturing eczema control.2 Initial validation work is encouraging, but RECAP’s validity in different populations and the reliability and responsiveness is uncertain.2,3

Original language	English
Journal	British Journal of Dermatology
DOIs	https://doi.org/10.1111/bjd.19709
Publication status	Accepted/In press - 30 Nov 2020

Access to Document

10.1111/bjd.19709

Embargoed Document

Full-text PDF (author accepted manuscript)
Accepted author manuscript, 196 KB
Embargo ends: 1/01/99
Request copy

Cite this

@article{6121c23dd7f34cd585b069153d32b731,

title = "Assessing the validity, responsiveness and reliability of the RECAP measure of eczema control",

abstract = "Research comparing the effectiveness of different eczema treatments is limited by inconsistency in both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for Eczema) recommends a core set of outcomes to be reported in all trials of eczema treatments.1 RECAP (RECap for AtoPic eczema) is a seven‐item patient‐reported instrument recommended for capturing eczema control.2 Initial validation work is encouraging, but RECAP{\textquoteright}s validity in different populations and the reliability and responsiveness is uncertain.2,3",

author = "Alisha Bhanot and TJ Peters and Ridd, {Matthew J}",

year = "2020",

month = nov,

day = "30",

doi = "10.1111/bjd.19709",

language = "English",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley",

}

TY - JOUR

T1 - Assessing the validity, responsiveness and reliability of the RECAP measure of eczema control

AU - Bhanot, Alisha

AU - Peters, TJ

AU - Ridd, Matthew J

PY - 2020/11/30

Y1 - 2020/11/30

N2 - Research comparing the effectiveness of different eczema treatments is limited by inconsistency in both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for Eczema) recommends a core set of outcomes to be reported in all trials of eczema treatments.1 RECAP (RECap for AtoPic eczema) is a seven‐item patient‐reported instrument recommended for capturing eczema control.2 Initial validation work is encouraging, but RECAP’s validity in different populations and the reliability and responsiveness is uncertain.2,3

AB - Research comparing the effectiveness of different eczema treatments is limited by inconsistency in both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for Eczema) recommends a core set of outcomes to be reported in all trials of eczema treatments.1 RECAP (RECap for AtoPic eczema) is a seven‐item patient‐reported instrument recommended for capturing eczema control.2 Initial validation work is encouraging, but RECAP’s validity in different populations and the reliability and responsiveness is uncertain.2,3

U2 - 10.1111/bjd.19709

DO - 10.1111/bjd.19709

M3 - Article (Academic Journal)

C2 - 33270215

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

ER -